Publication: Lipoprotein(a)-an interdisciplinary challenge
Lipoprotein(a)-an interdisciplinary challenge
Date
Date
Date
Citations
Julius, U., Tselmin, S., Schatz, U., Fischer, S., & Bornstein, S. R. (2019). Lipoprotein(a)-an interdisciplinary challenge. Clinical Research in Cardiology Supplements, 14(S1), 20–27. https://doi.org/10.1007/s11789-019-00098-0
Abstract
Abstract
Abstract
Lipoprotein(a) (Lp(a)) is an internationally recognized atherogenic risk factor which is inherited and not changed by nutrition or physical activity. At present, only proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors may modestly decrease its concentration (but not in all patients)-leading to a certain decrease in cardiovascular events (CVE) in controlled studies. However, at present an elevation of Lp(a) is not a generally accepted indication for their use. More effective is lipoprotein apheresis (LA) therapy with resp
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
- Julius, U
- Tselmin, S
- Schatz, U
- Fischer, S
- Bornstein, S R
Journal/Series Title
Journal/Series Title
Journal/Series Title
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Julius, U., Tselmin, S., Schatz, U., Fischer, S., & Bornstein, S. R. (2019). Lipoprotein(a)-an interdisciplinary challenge. Clinical Research in Cardiology Supplements, 14(S1), 20–27. https://doi.org/10.1007/s11789-019-00098-0
